The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Sublocade modified release solution for injection Indivior Pty Ltd
Product name
Sublocade modified release solution for injection
Sponsor
Accepted date
Jan-2025
Active ingredients
buprenorphine
Proposed indication
SUBLOCADE is for the treatment of opioid dependence, in parallel with other medical, social and psychological treatment.
Application type
C (new indication)
Publication date
Jan-2025